PRESS RELEASE – RSIP Vision Introduces AI-Based Multiplex IF Image Analysis Solution
SILICON VALLEY, Calif., Dec 3, 2019 — RSIP Vision, a global leader in artificial intelligence (AI), computer vision, and image processing technology, announced today that they are introducing an AI-based multiplex IF image analysis solution for precise results in tissue diagnosis. The new s...
Read MoreGlobal Big Data Conference:
January 21-23 in Santa Clara
RSIP Vision participates in the 4th Annual Global Big Data Conference 2020 in Santa Clara, CA. We have a very strong experience in Artificial Intelligence. Come and talk with us: we will be happy to discuss with you all your medical devices and digital health projects! You will also be able to fo...
Read MoreSPIE Photonics West:
February 2 in San Francisco
RSIP Vision participates in the SPIE Photonics West 2020 in Santa Clara, CA. We have a very strong experience in Artificial Intelligence. Come and talk with us: we will be happy to discuss with you all your medical devices and digital health projects! You will also be able to follow Moshe Safran&...
Read MoreIBM Symposium on AI for Biomedical Imaging:
February 4-5 in San Jose, CA
RSIP Vision participates in the Symposium on AI for Biomedical Imaging held by IBM in San Jose, CA. We have a very strong experience in Artificial Intelligence. Come and talk with us: we will be happy to discuss with you all your medical devices and digital health projects! You will also be able ...
Read MoreThe AI Summit:
December 11-12 in New York
RSIP Vision participates in the AI Summit 2019 in New York. We have a very strong experience in Artificial Intelligence. Come and talk with us: we will be happy to discuss with you all your medical devices and digital health projects! You will also be able to follow Moshe Safran’s talk on t...
Read MoreMultiplex IF Analysis
Multiplex IF analysis allows for real-time relational data between cells in tissue. This is an advantage over the gold standard brightfield IHC, which looks at a single marker at a time. When using brightfield IHC for multiple markers, sequential sections of the tissue are needed which does not a...
Read MoreAACR 2019:
March 29 – April 3 in Atlanta, GA
RSIP Vision participates in the AACR 2019 Annual Meeting. We are passionate about cancer research and will be happy to discuss your pharma projects with you. March 29 – April 3, 2019 in Atlanta, Georgia Contact Us
Read MoreAI Pharma Innovation:
Feb 27-28 in S.Francisco, CA
RSIP Vision participates in the AI Pharma Innovation Drug Discovery 2019 event. Meet with us: we are passionate about AI in pharma projects and will be happy to discuss with you. February 27-28, 2019 in S.Francisco, CA Contact Us
Read MoreTissue Analysis with AI
RSIP Vision is introducing Deep Learning in the biopsy analysis procedure. Here is how the benefits of tissue analysis with AI have become available. Biopsy is the key examination used to determine the presence of most malignant tumors. Notwithstanding its importance and the need for millions of ...
Read MoreDetection and Tracking of Tumors
RSIP Vision’s automated detection and tracking of tumors answers one of the most frequent needs in the pharma industry – assessment of patient response to a new drug. This very strong tool saves precious time in the clinical stage when the automated detection and tracking can supply the most accu...
Read MoreAutomated RECIST Measurement
RSIP Vision has develop an efficient tool for clinical trials in the pharma industry – the automated RECIST measurement. The gold standard in measuring the evolution of solid tumors, along the treatment with a tested drug, is the RECIST score (Response Evaluation Criteria in Solid Tumors), ...
Read MoreDetection and Segmentation of Dendritic Cells
Dendritic cells are a type of antigen-presenting cells and have an integral part in the normal functioning immune system, in that they help to initiate primary immune response. Dendritic cells are typically present in tissues that come in contact with the external environment. That includes the s...
Read More